Cellebrite DI (NASDAQ:CLBT – Free Report) had its price objective increased by JPMorgan Chase & Co. from $22.00 to $24.00 in ...
William Blair analyst Jonathan Ho has maintained their bullish stance on CLBT stock, giving a Buy rating today. Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily ...
Check the time stamp on this data. Updated AI-Generated Signals for Cellebrite Di Ltd. (CLBT) available here: CLBT.
Shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) have received an average recommendation of “Buy” from the eight research firms that are currently covering the company, Marketbeat.com ...
JPMorgan raised the firm’s price target on Cellebrite (CLBT) to $24 from $22 and keeps an Overweight rating on the shares. The firm updating ...
There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.